The Tech’o’Space Podcast Ep 102 - Accelerating the Future of Medtech Trials with AI and Theranostics

In this podcast episode, we are absolutely honored to interact and collaborate with Mr. Julio G. Martinez-Clark who is the Chief Executive Officer of Synapse Global Theranostics Inc. and the Podcast Host of bioaccess®. He is based out of Miami, Florida, USA.a) Gives a timeline of his journey from building telecom infrastructure at Nortel and Alcatel-Lucent to leading cross-border clinical trial operations as CEO of bioaccess®, Synapse Global Theranostics, and amavita Heart and Vascular Health®.b) Shares his experience of collaborating with over a hundred Medtech and Biopharma companies, streamlining regulatory paths and using machine learning to boost trial efficiency, radio pharma.c) Talks about the key strategies taken by him in helping to bridge the global teams and cultures in challenging markets pertaining to the Clinical AI Space.d) Mentions about his source of inspiration and drive to start his own podcast initiative "Global Trial Accelerators™" and, also talks about being a columnist at Med Device Online and having said that shares an interesting backstory associated with the two.e) Emphasizes on highlighting the key differences that he has observed while specializing in accelerating the medical innovations and clinical trials through unconventional markets like Latin America, the Balkans, and Australia.f) His take on how AI is disrupting the clinical research, regulatory strategies for tech in emerging economies, or building resilient, human trials during global disruptions.